title: Nucleolar changes after microinjection of antibodies to RNA polymerase I into the nucleus of mammalian cells.
abstract: After microinjection of antibodies against RNA polymerase I into the nuclei of cultured rat kangaroo (PtK2) and rat (RVF-SMC) cells alterations in nucleolar structure and composition were observed. These were detected by electron microscopy and double-label immunofluorescence microscopy using antibodies to proteins representative of the three major components of the nucleolus. The microinjected antibodies produced a progressive loss of the material of the dense fibrillar component (DFC) from the nucleoli which, at 4 h after injection, were transformed into bodies with purely granular component (GC) structure with attached fibrillar centers (FCs). Concomitantly, numerous extranucleolar aggregates appeared in the nucleoplasm which morphologically resembled fragments of the DFC and contained a protein (fibrillarin) diagnostic for this nucleolar structure. These observations indicate that the topological distribution of the material constituting the DFC can be experimentally influenced in interphase cells, apparently by modulating the transcriptional activity of the rRNA genes. These effects are different from nucleolar lesions induced by inhibitory drugs such as actinomycin D-dependent "nucleolar segregation". The structural alterations induced by antibodies to RNA polymerase I resemble, however, the initial events of nucleolar disintegration during mitotic prophase.
authors.affiliation: Institute of Zoology I, University of Würzburg, Federal Republic of Germany.
authors.forename: R
authors.initials: R
authors.lastname: Benavente
authors.forename: G
authors.initials: G
authors.lastname: Reimer
authors.forename: K M
authors.initials: KM
authors.lastname: Rose
authors.forename: B
authors.initials: B
authors.lastname: Hügle-Dörr
authors.forename: U
authors.initials: U
authors.lastname: Scheer
mesh_terms: D000818:Animals; D000906:Antibodies / Q000008:administration & dosage; D002466:Cell Nucleolus / Q000187:drug effects / Q000201:enzymology / Q000648:ultrastructure*; D002467:Cell Nucleus / Q000201:enzymology; D002478:Cells, Cultured; D004275:DNA, Ribosomal / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology; D008845:Microinjections; D008854:Microscopy, Electron; D012318:RNA Polymerase I / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism; D014158:Transcription, Genetic
chemical_list: D000906:Antibodies; D004275:DNA, Ribosomal; D003609:Dactinomycin; D012318:RNA Polymerase I